105 related articles for article (PubMed ID: 21436738)
21. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis.
Dumon-Jones V; Frappart PO; Tong WM; Sajithlal G; Hulla W; Schmid G; Herceg Z; Digweed M; Wang ZQ
Cancer Res; 2003 Nov; 63(21):7263-9. PubMed ID: 14612522
[TBL] [Abstract][Full Text] [Related]
22. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
23. Heterozygous p.I171V mutation of the
Kałużna EM; Rembowska J; Ziółkowska-Suchanek I; Świątek-Kościelna B; Gabryel P; Dyszkiewicz W; Nowak JS
Oncol Lett; 2015 Nov; 10(5):3300-3304. PubMed ID: 26722329
[TBL] [Abstract][Full Text] [Related]
24. Fertility defects revealing germline biallelic nonsense NBN mutations.
Warcoin M; Lespinasse J; Despouy G; Dubois d'Enghien C; Laugé A; Portnoï MF; Christin-Maitre S; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2009 Mar; 30(3):424-30. PubMed ID: 19105185
[TBL] [Abstract][Full Text] [Related]
25. Biology and therapy of malignant solid tumors in childhood.
van den Berg H
Cancer Chemother Biol Response Modif; 2002; 20():605-25. PubMed ID: 12703226
[No Abstract] [Full Text] [Related]
26. Three germline mutations in the TP53 gene.
Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
[TBL] [Abstract][Full Text] [Related]
27. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes.
Porhanova NV; Sokolenko AP; Sherina NY; Ponomariova DN; Tkachenko NN; Matsko DE; Imyanitov EN
Cancer Genet Cytogenet; 2008 Oct; 186(2):122-4. PubMed ID: 18940477
[No Abstract] [Full Text] [Related]
30. Inherited NBN Mutations and Prostate Cancer Risk and Survival.
Rusak B; Kluźniak W; Wokołorczykv D; Stempa K; Kashyap A; Gronwald J; Huzarski T; Dębniak T; Jakubowska A; Masojć B; Akbari MR; Narodv SA; Lubiński J; Cybulski C
Cancer Res Treat; 2019 Jul; 51(3):1180-1187. PubMed ID: 30590007
[TBL] [Abstract][Full Text] [Related]
31. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.
Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J
Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123
[TBL] [Abstract][Full Text] [Related]
32. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
33. Germline ATBF1 mutations and prostate cancer risk.
Xu J; Sauvageot J; Ewing CM; Sun J; Liu W; Isaacs SD; Wiley KE; Diaz L; Zheng SL; Walsh PC; Isaacs WB
Prostate; 2006 Jul; 66(10):1082-5. PubMed ID: 16637072
[TBL] [Abstract][Full Text] [Related]
34. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of p53 gene in childhood malignant solid tumors.
Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
[TBL] [Abstract][Full Text] [Related]
36. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood stem cells in children with solid tumors. Part II. Immunocytologic detection of tumor cells in bone marrow and peripheral blood stem cell harvests.
Dominici C; Deb G; Angioni A; Landolfo A; Parisi F; Helson L; Donfrancesco A
Anticancer Res; 1993; 13(6B):2573-5. PubMed ID: 8135496
[TBL] [Abstract][Full Text] [Related]
38. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
[TBL] [Abstract][Full Text] [Related]
39. Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
Perotti D; De Vecchi G; Testi MA; Lualdi E; Modena P; Mondini P; Ravagnani F; Collini P; Di Renzo F; Spreafico F; Terenziani M; Sozzi G; Fossati-Bellani F; Radice P
Hum Mutat; 2004 Nov; 24(5):400-7. PubMed ID: 15459955
[TBL] [Abstract][Full Text] [Related]
40. Effect of hyperthermia 42.5 degrees C/120 min on 3H-thymidine incorporation in different tissue components of Wilms' tumors: an in vitro study.
Willnow U; Dumon K; Godehardt E
Klin Padiatr; 1996; 208(4):145-50. PubMed ID: 8776702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
